(Stroke. 1997;28:537-542.)
© 1997 American Heart Association, Inc.
Articles |
From the Units of Neurology (G.A., L.F., F.N., R.D'A.), Clinical Pharmacology and Therapeutics (L.B.), and Emergency Medicine (G.R.), S Orsola-Malpighi Hospital, Bologna, and Cesena Local Health Care Authority, Medical Health Care Management Unit (U.M., D.C.), Italy.
Correspondence to Dr Giuseppe Azzimondi, Servizio di Neurologia, Ospedale S Orsola-Malpighi, Via Albertoni 15, 40138 Bologna, Italy. E-mail clinphar{at}orsola.med.unibo.it.
Background and Purpose A limiting criterion for the eligibility of patients in clinical trials investigating acute stroke therapies is that time between onset of symptoms and arrival in the hospital should fall within the "therapeutic window." The aims of this study were to estimate hospital arrival time in an unselected sample of stroke patients, to assess the association with some clinical and demographic variables, and to evaluate the effects of the delay on the clinical efficiency of an effective treatment.
Methods We evaluated the delay in hospital arrival time in 189 patients (84 men, 105 women; mean age, 76.5 years) prospectively collected in the S Orsola-Malpighi Community Teaching Hospital in Bologna, Italy. Cutoffs of 2 and 5 hours were chosen to allow for hypothetical treatment within 3 and 6 hours, respectively. Exact multiple logistic regression was used to predict the delay as a function of dichotomized age, sex, symptoms on awakening, day of the week, hour of the day, area of residence, level of consciousness, and level of motor power defect. We then projected the effectiveness of tissue plasminogen activator (TPA) on disability as estimated with the aid of the odds ratio from the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Trial onto our unselected sample to evaluate clinical efficiency of treatment as a function of arrival time and of hypothetical effects of educational efforts to reduce it.
Results The mean interval between onset of symptoms and
hospital arrival was 680 minutes; 59 patients (31%) arrived within 2
hours and 100 (53%) within 5 hours. Onset of symptoms when awake,
drowsiness or coma, and paralysis of at least one limb were the only
independent predictors of hospital arrival within 2 and 5 hours in both
the total sample and the subgroup of patients who were awake at stroke
onset. The effectiveness of 17%, extrapolated with the aid of the odds
ratio of 1.6 of having a favorable outcome (Barthel Index
95 at 3
months) in treated versus untreated patients in the NINDS rt-PA Stroke
Trial, corresponded to a projected clinical efficiency of 5%. This
could be doubled by hypothesizing a 100% effect of educational efforts
in reducing the delay in hospital arrival time.
Conclusions Patients with milder symptoms, for whom treatment might be more effective, were less likely to arrive in time for therapy. The proposed model of the relationship between the delay in hospital presentation after a stroke and the clinical efficiency of a given treatment might be useful for planning future clinical trials on early stroke treatment and predicting the impact of an educational program aimed at shortening arrival time.
Key Words: disability evaluation hospitalization models, theoretical stroke management
This article has been cited by other articles:
![]() |
G. Saposnik, J. Fang, M. O'Donnell, V. Hachinski, M. K. Kapral, M. D. Hill, and on behalf of the Investigators of the Registry of Escalating Levels of Access to In-Hospital Care and Stroke Mortality Stroke, September 1, 2008; 39(9): 2522 - 2530. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Saposnik, M. D. Hill, M. O'Donnell, J. Fang, V. Hachinski, M. K. Kapral, and on behalf of the investigators of the Registry of Variables Associated With 7-Day, 30-Day, and 1-Year Fatality After Ischemic Stroke Stroke, August 1, 2008; 39(8): 2318 - 2324. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Maestroni, C Mandelli, D Manganaro, B Zecca, P Rossi, V Monzani, and G Torgano Factors influencing delay in presentation for acute stroke in an emergency department in Milan, Italy Emerg. Med. J., June 1, 2008; 25(6): 340 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Juhl Majersik, M. A. Smith, D. B. Zahuranec, B. N. Sanchez, and L. B. Morgenstern Population-Based Analysis of the Impact of Expanding the Time Window for Acute Stroke Treatment Stroke, December 1, 2007; 38(12): 3213 - 3217. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hodgson, P. Lindsay, and F. Rubini Can Mass Media Influence Emergency Department Visits for Stroke? Stroke, July 1, 2007; 38(7): 2115 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dawson and M. Walters New and emerging treatments for stroke Br. Med. Bull., November 7, 2006; (2006) ldl011v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Moser, L. P. Kimble, M. J. Alberts, A. Alonzo, J. B. Croft, K. Dracup, K. R. Evenson, A. S. Go, M. M. Hand, R. U. Kothari, et al. Reducing Delay in Seeking Treatment by Patients With Acute Coronary Syndrome and Stroke: A Scientific Statement From the American Heart Association Council on Cardiovascular Nursing and Stroke Council Circulation, July 11, 2006; 114(2): 168 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Qureshi, J. F. Kirmani, M. A. Sayed, A. Safdar, S. Ahmed, R. Ferguson, L. A. Hershey, K. J. Qazi, and for the Buffalo Metropolitan Area and Erie County Time to hospital arrival, use of thrombolytics, and in-hospital outcomes in ischemic stroke Neurology, June 28, 2005; 64(12): 2115 - 2120. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kwan, P. Hand, and P. Sandercock Improving the efficiency of delivery of thrombolysis for acute stroke: a systematic review QJM, May 1, 2004; 97(5): 273 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Stahl, K. L. Furie, S. Gleason, and G. S. Gazelle Stroke: Effect of Implementing an Evaluation and Treatment Protocol Compliant with NINDS Recommendations Radiology, September 1, 2003; 228(3): 659 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Morgenstern, L. Staub, W. Chan, T. H. Wein, L. K. Bartholomew, M. King, R. A. Felberg, W. S. Burgin, J. Groff, S. L. Hickenbottom, et al. Improving Delivery of Acute Stroke Therapy: The TLL Temple Foundation Stroke Project Stroke, January 1, 2002; 33(1): 160 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Lacy, D.-C. Suh, M. Bueno, and J. B. Kostis Delay in Presentation and Evaluation for Acute Stroke : Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.) Stroke, January 1, 2001; 32(1): 63 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wester, J. Radberg, B. Lundgren, and M. Peltonen Factors Associated With Delayed Admission to Hospital and In-Hospital Delays> in Acute Stroke and TIA : A Prospective, Multicenter Study Stroke, January 1, 1999; 30(1): 40 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pantoni, C. Sarti, and D. Inzitari Cytokines and Cell Adhesion Molecules in Cerebral Ischemia : Experimental Bases and Therapeutic Perspectives Arterioscler Thromb Vasc Biol, April 1, 1998; 18(4): 503 - 513. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |